JMP Securities Raises Larimar Therapeutics (NASDAQ:LRMR) Price Target to $25.00
Larimar Therapeutics (NASDAQ:LRMR – Free Report) had its price objective hoisted by JMP Securities from $17.00 to $25.00 in a research report report published on Tuesday morning, Benzinga reports. They currently have a market outperform rating on the stock. Separately, Citigroup raised shares of Larimar Therapeutics from a neutral rating to a buy rating and […]
More Stories
Microsoft Corporation (NASDAQ:MSFT) Holdings Increased by 626 Financial LLC
626 Financial LLC lifted its holdings in Microsoft Corporation (NASDAQ:MSFT – Free Report) by 7.6% in the 1st quarter, according...
GAMMA Investing LLC Increases Stock Holdings in ATI Inc. (NYSE:ATI)
GAMMA Investing LLC raised its position in ATI Inc. (NYSE:ATI – Free Report) by 39.2% in the 1st quarter, according...
GAMMA Investing LLC Boosts Holdings in Affirm Holdings, Inc. (NASDAQ:AFRM)
GAMMA Investing LLC boosted its holdings in Affirm Holdings, Inc. (NASDAQ:AFRM – Free Report) by 10.0% in the 1st quarter,...
Harbor Group Inc. Has $685,000 Position in Microsoft Corporation (NASDAQ:MSFT)
Harbor Group Inc. reduced its holdings in Microsoft Corporation (NASDAQ:MSFT – Free Report) by 1.6% in the first quarter, HoldingsChannel...
Wealth Enhancement Advisory Services LLC Acquires 643 Shares of MarketAxess Holdings Inc. (NASDAQ:MKTX)
Wealth Enhancement Advisory Services LLC boosted its holdings in MarketAxess Holdings Inc. (NASDAQ:MKTX – Free Report) by 23.8% during the...
Illinois Municipal Retirement Fund Decreases Stock Holdings in NV5 Global, Inc. (NASDAQ:NVEE)
Illinois Municipal Retirement Fund reduced its stake in shares of NV5 Global, Inc. (NASDAQ:NVEE – Free Report) by 7.8% in...